136 related articles for article (PubMed ID: 2217473)
1. Second line treatment of hormone refractory prostatic cancer patients.
Collste LG
Prog Clin Biol Res; 1990; 357():29-37. PubMed ID: 2217473
[No Abstract] [Full Text] [Related]
2. [Hormonal, radiation and combined therapy of locally advanced prostatic cancer (T3NXM0)].
Pavlov AS; Loran OB; Simakina EP; Tomkevich BA; Repina AG; Gribova RG
Urologiia; 2005; (4):24-6. PubMed ID: 16158741
[TBL] [Abstract][Full Text] [Related]
3. [The late results of the combined hormonal chemoradiation treatment of prostatic cancer].
Sviridova TV; Mardynskiĭ IuS; Tsodikova LB; Rozhkov OV
Urol Nefrol (Mosk); 1996; (1):31-4. PubMed ID: 8659040
[TBL] [Abstract][Full Text] [Related]
4. [New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S
Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364
[No Abstract] [Full Text] [Related]
5. The role of chemotherapy in the treatment of prostatic carcinoma.
Tonato M; Bracarda S
Rays; 1993; 18(1):87-93. PubMed ID: 8356244
[No Abstract] [Full Text] [Related]
6. [Treatment of advanced prostate cancer].
Okada K; Akino H; Suzuki Y; Miwa Y; Saikawa S; Fujita T; Aoki Y; Iwaoka K
Hinyokika Kiyo; 1994 Oct; 40(10):945-50. PubMed ID: 7992712
[TBL] [Abstract][Full Text] [Related]
7. Hormone chemotherapy for newly diagnosed patients with metastatic prostate cancer.
Kubota Y; Nakada T; Suzuki Y; Iizima Y; Adachi Y; Hashimoto T
Int Urol Nephrol; 1993; 25(5):469-74. PubMed ID: 8270375
[TBL] [Abstract][Full Text] [Related]
8. [Incorrect about hormone treatment in prostatic cancer].
Fosså SD; Egey A; Haukaas SA; Angelsen A; Klepp O; Berge V; Axcrona K; Lilleby W
Tidsskr Nor Laegeforen; 2009 Feb; 129(5):429. PubMed ID: 19247406
[No Abstract] [Full Text] [Related]
9. [Prostatic adenocarcinoma. I. History of its treatment and study of its prognostic factors. Review of the literature].
Valls Fontanals A; Panadés Nigorra G; Ballester Moll T
Actas Urol Esp; 1985; 9(2):109-14. PubMed ID: 3893052
[No Abstract] [Full Text] [Related]
10. The management of end-stage carcinoma of the prostate: philosophy and fact.
Robinson MR
Prog Clin Biol Res; 1990; 357():39-44. PubMed ID: 2217476
[No Abstract] [Full Text] [Related]
11. Atrasentan demonstrates survival benefit in hormone-refractory prostate cancer.
Expert Rev Anticancer Ther; 2002 Jun; 2(3):245. PubMed ID: 12113043
[No Abstract] [Full Text] [Related]
12. Management of newly diagnosed metastatic carcinoma of the prostate.
Elder JS; Catalona WJ
Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic and therapeutic aspects of prostatic carcinoma].
Studer UE
Schweiz Rundsch Med Prax; 1988 May; 77(20):545-50. PubMed ID: 3291053
[No Abstract] [Full Text] [Related]
14. [Therapeutic problems in hormone-dependent cancer].
Zimel H
Stud Cercet Endocrinol; 1969; 20(2):111-25. PubMed ID: 4898947
[No Abstract] [Full Text] [Related]
15. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?
Gofrit ON; Pode D; Pizov G; Zorn KC; Katz R; Shapiro A
BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623
[TBL] [Abstract][Full Text] [Related]
16. [Advanced prostatic carcinoma--which hormone therapy when?].
Studer UE
Urologe A; 1995 Sep; 34(5):361-6. PubMed ID: 7483151
[No Abstract] [Full Text] [Related]
17. [Therapy of advanced prostatic cancer].
Sagaster P; Flamm J
Wien Med Wochenschr; 1988 Apr; 138(8):169-73. PubMed ID: 3043920
[TBL] [Abstract][Full Text] [Related]
18. Current strategies in the treatment of metastatic hormone-refractory prostate cancer.
Ghosn M; Kattan J; Younes F
Tunis Med; 2005 Dec; 83 Suppl 12():74. PubMed ID: 16430073
[No Abstract] [Full Text] [Related]
19. [Treatment for hormone-refractory or relapsing prostatic cancer].
Hirao Y; Ozono S; Okajima E
Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: metastatic.
Michaelson D; Talcott J; Smith M
Clin Evid; 2002 Jun; (7):804-11. PubMed ID: 12230706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
